Dexrabeprazole is a novel Proton Pump Inhibitor which is used in the treatment of acid peptic disease, gastroesophageal reflux disease (GERD) maintenance therapy , erosive esophagitis, short term treatment of active duodenal and Zollinger-Ellison syndrome and treatment of H-pylori induced ulcers. Dexrabeprazole is better than other PPI in terms of favourable Pharmacokinetics, more efficacy, longer half life, better healing of esophagitis and fastly symptom control. It is superior than other PPIs at half the strength.